H.C. Wainwright Reiterates Buy Rating on Neumora Therapeutics (NMRA)

Go back to H.C. Wainwright Reiterates Buy Rating on Neumora Therapeutics (NMRA)
(NASDAQ: NMRA) Delayed: 1.49 -0.07 (4.49%)
Previous Close $1.56    52 Week High
Open $1.54    52 Week Low
Day High $1.54    P/E N/A 
Day Low $1.46    EPS
Volume 665,736